Silk Road Medical shares are trading higher after the company announced FDA approval for expanded indications for the ENROUTE stent to include patients at standard risk for adverse events from carotid endarterectomy.

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!